PODD Stock Analysis: Buy, Sell, or Hold?
PODD - Insulet Corporation
$255.81
0.71 (0.28%)
▲
HOLD
LOW Confidence
Last Updated: January 30, 2026
Earnings: Feb 18, 2026
16d
Get Alerted When PODD Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: PODD shows mixed signals. Fine to hold existing positions. Not urgent to buy or sell.
📊 HOLD: PODD shows mixed signals. Fine to hold existing positions. Not urgent to buy or sell.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$300.90
Based on 14.5% avg growth
INTRINSIC VALUE TODAY
$186.83
Trading above fair value
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 25.0x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: PODD is currently trading at $255.81, which is considered oversold relative to its 30-day fair value range of $274.38 to $292.22. From a valuation perspective, the stock is trading at a discount (Forward PE: 41.4) compared to its historical average (47.4). Remarkably, the market is currently pricing in an annual earnings decline of 4.4% over the next few years. This pessimistic expectation contrasts with the company's recent 14.8% earnings growth, suggesting potential undervaluation if the company simply maintains stability.
Technical Outlook: Technically, PODD is in a strong downtrend. The price is currently testing key support at $253.04. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $370.44 (+44.8%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, PODD is in a strong downtrend. The price is currently testing key support at $253.04. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $370.44 (+44.8%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
OVERSOLD
Fair Price Range
$274.38 -
$292.22
Company Quality Score
54/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
79.5%
Protect Your Profits
Holding PODD? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanAll Signals
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Mixed technical signals (40/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 44.8% below Wall St target ($370.44)
- CAUTION: Recommendation downgraded due to -5.8% 5-day decline
Fair Price Analysis
30-Day Fair Range
$274.38 -
$292.22
Current vs Fair Value
OVERSOLD
Support & Resistance Levels
Support Level
$253.04
Resistance Level
$289.26
Current Trend
Strong Downtrend
Fundamental Context
Forward P/E (Next Year Est.)
41.39
Wall Street Target
$370.44
(+44.8%)
Revenue Growth (YoY)
29.9%
Earnings Growth (YoY)
14.8%
Profit Margin
9.8%
Valuation Discount vs History
-4.4% cheaper
PE vs Historical
41.4 vs 47.4
CHEAP
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-4.4%
(market-implied from PE analysis)
1-Year Target
$244.55
(-4%)
2-Year Target
$233.79
(-9%)
3-Year Target
$223.51
(-13%)
3-Yr Target (if PE normalizes)
(PE: 41→47)
$255.97
(+0%)
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 41.4, Growth: 26.3%)
$515.41
(+102%)
Base:
(SPY PE: 22.3, Growth: 26.3%)
$277.70
(+9%)
Bear:
(PE: 19.0, Growth: 26.3%)
$236.04
(-8%)
📈
Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (43x PE), but valuation improves significantly next year (41x PE) as earnings recover.
Forward PE: 43.48 | Forward EPS (Implied): $5.88
Bull Case
$308.89
(+21%)
Analyst growth 15.0%, PE expands to 45.7
Base Case
$255.81
(0%)
Market implied 0.0%, PE stable at 43.5
Bear Case
$195.69
(-24%)
Severe decline -15.0%, PE contracts to 39.1
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
💡
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 41.4 to 47.4
Stabilization Target:
$292.96
(+14.5%)
PE Expansion Potential:
+14.5%
Last updated: January 31, 2026 11:14 PM ET
Data refreshes hourly during market hours. Next update: 12:14 AM
Data refreshes hourly during market hours. Next update: 12:14 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is PODD showing a specific setup today?
Insider Activity (6 Months)
0
Buys
2
Sells
Net
INSIDERS SELLING
Recent Transactions
Laetitia Cousin
SELL
797 shares
2025-09-08
Prem Singh
SELL
687 shares
2025-09-08
Top Rated Medical Devices Stocks
Top-rated stocks in Medical Devices by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
BSX
Boston Scientific Corp |
STRONG BUY
34 analysts |
$124 | 59 HOLD |
|
DXCM
DexCom Inc |
STRONG BUY
26 analysts |
$85 | 65 BUY |
|
ABT
Abbott Laboratories |
BUY
28 analysts |
$136 | 63 BUY |
|
MDT
Medtronic PLC |
BUY
32 analysts |
$110 | 63 BUY |
|
GEHC
GE HealthCare Technologi… |
STRONG BUY
21 analysts |
$92 | 60 HOLD |
Advanced PODD Option Strategies
Professional options setups generated by AI based on today's PODD price and gamma walls.
